Lnova
樓主RoadToMoreMs
:
CEO has talked about their two drugs and how they have been effective in crossing the blood brain barrier and treating brain tumors
Lnova
樓主
:
Question just asked is whether CNSP is in full compliance with NASDAQ requirements. It sounds like they have confirmed that they are, that they need to have the share price reach 1 dollar or more, which they hope that good news will bring about
Lnova
樓主
:
They say that they have indication that their drugs are safe. That their drugs prolong life expectancy for those diagnosed with this type of brain cancer
RoadToMoreMs : Can’t watch, update us pls
Lnova 樓主 RoadToMoreMs : k
RoadToMoreMs : Any good news?
Lnova 樓主 RoadToMoreMs : CEO has talked about their two drugs and how they have been effective in crossing the blood brain barrier and treating brain tumors
Lnova 樓主 : Question just asked is whether CNSP is in full compliance with NASDAQ requirements. It sounds like they have confirmed that they are, that they need to have the share price reach 1 dollar or more, which they hope that good news will bring about
Lnova 樓主 : They say that they have indication that their drugs are safe. That their drugs prolong life expectancy for those diagnosed with this type of brain cancer
Lnova 樓主 : Next question: will there be an upcoming reverse split? CEO says that he hopes not, and that the stock is trading at a significant discount
Lnova 樓主 : CEO says that he believes the stock will recover, is a deeply undervalued stock
Lnova 樓主 : CEO says that they have enough cash to complete the Berubicin study
Lnova 樓主 : Q&A has been good inspiring
查看更多評論...